source
- Supernus and Individor to merge, creating $2 billion brain-drug companySupernus and Individor announced a merger that will combine their portfolios of neurological medicines. The two firms together generated about $2 billion in revenue in 2025 from roughly a dozen CN…
- Moderna awaits FDA decision on mRNA flu vaccine as biotech fund launches and pricing disputes intensifyModerna is awaiting the FDA's decision on its mRNA influenza vaccine, which could become the first seasonal flu shot using messenger RNA technology. Meanwhile, venture firm TCGX announced a new $4…